LL

Laurus Labs Ltd

NSE : LAURUSLABS
BSE: 540222
SECTOR : PHARMACEUTICALS
No data to show from BSE
52w high/low icon
52w high/low
₹723.75 / ₹333.05
P/E ratio icon
P/E ratio
133.82
Dividend icon
Dividend
0.14
ROE icon
ROE
5.51
ROCE icon
ROCE
7.15
Face value icon
Face value
2
Book value icon
Book value
₹79.19Cr
Market capital icon
Market capital
₹31,457.25Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.
Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:
Assets = Liabilities + Shareholder's Equity
This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

PE TTM
133.82
P/B
7.37
ROE
5.51
ROCE
7.15
Dividend yield
0.14%
EPS TTM
4.36
EBTIDA Growth
-46.77
D/E
0.55
Sector PE
47.77
BV
₹79.19Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.
LL

About Laurus Labs Ltd

Laurus Labs is a leading research and development ('R&D') driven pharmaceutical company in India, with a leadership position in generic active pharmaceutical ingredients ('APIs') for select, high-growth therapeutic areas of anti-retrovirals ('ARVs'), Hepatitis C and Oncology. The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others. The company currently operates four manufacturing facilities in Visakhapatnam, Andhra Pradesh. Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API. The company's strategic and early investments in R&D and manufacturing infrastructure has enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing 'donor-funded access-to-medicines markets' of Sub-Saharan Africa, South-East Asia and Latin America. The company also has growing synthesis and nutraceutical/ cosmeceutical ingredients businesses. Further, it is increasingly focused towards growing its integrated generics finished dosage forms ('FDFs') business in which it has made significant investments. Laurus Labs operates in four business lines: Generics - APIs, Generics - FDFs, Synthesis and Ingredients.

Key info

Address
Plot No 21 Jawaharlal Nehru, Pharma City Parawada, Visakhapatnam, Andhra Pradesh, 531021
Fax Nos.
91-891-3061270
Telephone Nos.
91-891-3061222
Email
secretarial@lauruslabs.com
fbtwitterlinkedingithubinstagramyoutube